PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Consumables – Market size and forecast 2018-2023
• Systems – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Oncology – Market size and forecast 2018-2023
• Diabetes – Market size and forecast 2018-2023
• Gastroenterology – Market size and forecast 2018-2023
• Anesthesia, critical care, and pain management – Market size and
• forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Development of wireless smart syringe pumps
• Advent of microinfusion and non-magnetic syringe pumps
• Market expansion in emerging economies
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• B. Braun Melsungen AG
• Baxter
• BD
• IRadimed Corporation
• Smiths Group plc
• TERUMO CORPORATION
PART 15: APPENDIX
• Research methodology
• List of abbreviations
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Product – Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Consumables – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Consumables – Year-over-year growth 2019-2023 (%)
Exhibit 21: Systems – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Systems – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Application – Market share 2018-2023 (%)
Exhibit 25: Comparison by application
Exhibit 26: Oncology – Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Oncology – Year-over-year growth 2019-2023 (%)
Exhibit 28: Diabetes – Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Diabetes – Year-over-year growth 2019-2023 (%)
Exhibit 30: Gastroenterology – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Gastroenterology – Year-over-year growth 2019-2023 (%)
Exhibit 32: Anesthesia, critical care, and pain management – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Anesthesia, critical care, and pain management – Year-over-year growth 2019-2023 (%)
Exhibit 34: Others – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Others – Year-over-year growth 2019-2023 (%)
Exhibit 36: Market opportunity by application
Exhibit 37: Customer landscape
Exhibit 38: Market share by geography 2018-2023 (%)
Exhibit 39: Geographic comparison
Exhibit 40: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 41: North America – Year-over-year growth 2019-2023 (%)
Exhibit 42: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 43: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 44: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 45: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 46: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 47: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 48: Key leading countries
Exhibit 49: Market opportunity
Exhibit 50: Impact of drivers and challenges
Exhibit 51: Vendor landscape
Exhibit 52: Landscape disruption
Exhibit 53: Vendors covered
Exhibit 54: Vendor classification
Exhibit 55: Market positioning of vendors
Exhibit 56: B. Braun Melsungen AG – Vendor overview
Exhibit 57: B. Braun Melsungen AG – Business segments
Exhibit 58: B. Braun Melsungen AG – Organizational developments
Exhibit 59: B. Braun Melsungen AG – Geographic focus
Exhibit 60: B. Braun Melsungen AG – Segment focus
Exhibit 61: B. Braun Melsungen AG – Key offerings
Exhibit 62: Baxter – Vendor overview
Exhibit 63: Baxter – Business segments
Exhibit 64: Baxter – Organizational developments
Exhibit 65: Baxter – Geographic focus
Exhibit 66: Baxter – Segment focus
Exhibit 67: Baxter – Key offerings
Exhibit 68: BD – Vendor overview
Exhibit 69: BD – Business segments
Exhibit 70: BD – Organizational developments
Exhibit 71: BD – Geographic focus
Exhibit 72: BD – Segment focus
Exhibit 73: BD – Key offerings
Exhibit 74: IRadimed Corporation – Vendor overview
Exhibit 75: IRadimed Corporation – Business segments
Exhibit 76: IRadimed Corporation – Geographic focus
Exhibit 77: IRadimed Corporation – Key offerings
Exhibit 78: Smiths Group plc – Vendor overview
Exhibit 79: Smiths Group plc – Business segments
Exhibit 80: Smiths Group plc – Organizational developments
Exhibit 81: Smiths Group plc – Geographic focus
Exhibit 82: Smiths Group plc – Segment focus
Exhibit 83: Smiths Group plc – Key offerings
Exhibit 84: TERUMO CORPORATION – Vendor overview
Exhibit 85: TERUMO CORPORATION – Business segments
Exhibit 86: TERUMO CORPORATION – Organizational developments
Exhibit 87: TERUMO CORPORATION – Geographic focus
Exhibit 88: TERUMO CORPORATION – Segment focus
Exhibit 89: TERUMO CORPORATION – Key offerings
Exhibit 90: Validation techniques employed for market sizing
【掲載企業】
B. Braun Melsungen AG, Baxter, BD, IRadimed Corporation, Smiths Group plc, TERUMO CORPORATION
【免責事項】
https://www.globalresearch.jp/disclaimer